Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Healthcare CRO Services Market, by Service Type
1.4.2 Asia Pacific Healthcare CRO Services Market, by End User
1.4.3 Asia Pacific Healthcare CRO Services Market, by Therapeutic Area
1.4.4 Asia Pacific Healthcare CRO Services Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, Aug – 2020, Mar) Leading Players
Chapter 4. Asia Pacific Healthcare CRO Services Market by Service Type
4.1 Asia Pacific Clinical Research Services Market by Country
4.2 Asia Pacific Early Phase Development Market by Country
4.3 Asia Pacific Laboratory Services Market by Country
4.4 Asia Pacific Consulting Services Market by Country
Chapter 5. Asia Pacific Healthcare CRO Services Market by End User
5.1 Asia Pacific Pharmaceutical Sector Market by Country
5.2 Asia Pacific Medical Device Sector Market by Country
5.3 Asia Pacific Academic Institutes Market by Country
Chapter 6. Asia Pacific Healthcare CRO Services Market by Therapeutic Areas
6.1 Asia Pacific Oncology Market by Country
6.2 Asia Pacific CNS Disorder Market by Country
6.3 Asia Pacific Cardiovascular Disease Market by Country
6.4 Asia Pacific Diabetes Market by Country
6.5 Asia Pacific Metabolic Diseases Market by Country
6.5.1 Asia Pacific Infectious Diseases Market by Country
6.5.2 Asia Pacific Other therapeutic areas Market by Country
Chapter 7. Asia Pacific Healthcare CRO Services Market by Country
7.1 China Healthcare CRO Services Market
7.1.1 China Healthcare CRO Services Market by Service Type
7.1.2 China Healthcare CRO Services Market by End User
7.1.3 China Healthcare CRO Services Market by Therapeutic Areas
7.2 Japan Healthcare CRO Services Market
7.2.1 Japan Healthcare CRO Services Market by Service Type
7.2.2 Japan Healthcare CRO Services Market by End User
7.2.3 Japan Healthcare CRO Services Market by Therapeutic Areas
7.3 India Healthcare CRO Services Market
7.3.1 India Healthcare CRO Services Market by Service Type
7.3.2 India Healthcare CRO Services Market by End User
7.3.3 India Healthcare CRO Services Market by Therapeutic Area
7.4 South Korea Healthcare CRO Services Market
7.4.1 South Korea Healthcare CRO Services Market by Service Type
7.4.2 South Korea Healthcare CRO Services Market by End User
7.4.3 South Korea Healthcare CRO Services Market by Therapeutic Area
7.5 Singapore Healthcare CRO Services Market
7.5.1 Singapore Healthcare CRO Services Market by Service Type
7.5.2 Singapore Healthcare CRO Services Market by End User
7.5.3 Singapore Healthcare CRO Services Market by Therapeutic Area
7.6 Malaysia Healthcare CRO Services Market
7.6.1 Malaysia Healthcare CRO Services Market by Service Type
7.6.2 Malaysia Healthcare CRO Services Market by End User
7.6.3 Malaysia Healthcare CRO Services Market by Therapeutic Area
7.7 Rest of Asia Pacific Healthcare CRO Services Market
7.7.1 Rest of Asia Pacific Healthcare CRO Services Market by Service Type
7.7.2 Rest of Asia Pacific Healthcare CRO Services Market by End User
7.7.2.1.1 Rest of Asia Pacific Healthcare CRO Services Market by Therapeutic Areas
Chapter 8. Company Profiles
8.1 IQVIA Holdings, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Recent strategies and developments:
8.1.4.1 Product Launches and Product Expansions:
8.2 Laboratory Corporation of America Holdings (Covance, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.1 Recent strategies and developments:
8.2.1.1 Product Launches and Product Expansions:
8.2.1.2 Acquisition and Mergers:
8.2.1.3 Geographical Expansions:
8.3 Pharmaceutical Product Development, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Recent strategies and developments:
8.3.4.1 Geographical Expansions:
8.3.4.2 Acquisition and Mergers:
8.3.4.3 Partnerships, Collaborations, and Agreements:
8.4 Parexel International Corporation (Pamplona Capital Management)
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Acquisition and Mergers:
8.4.2.2 Partnerships, Collaborations, and Agreements:
8.5 Charles River Laboratories International, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Recent strategies and developments:
8.5.4.1 Acquisition and Mergers:
8.5.4.2 Partnerships, Collaborations, and Agreements:
8.6 ICON PLC
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Recent strategies and developments:
8.6.4.1 Product Launches and Product Expansions:
8.6.4.2 Acquisition and Mergers:
8.6.4.3 Partnerships, Collaborations, and Agreements:
8.7 Dassault Systemes SE (Medidata Solutions, Inc.)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.8 Syneos Health, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Recent strategies and developments:
8.8.4.1 Partnerships, Collaborations, and Agreements:
8.9 Pharmaron Beijing Co., Ltd.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Acquisition and Mergers:
8.1 GVK Biosciences Private Limited
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Partnerships, Collaborations, and Agreements:
Unique Offerings 
